Zobrazeno 1 - 10
of 124
pro vyhledávání: '"Martin, Haag"'
Autor:
Joseph Tintelnot, Alexander Stein, Salah-Eddin Al-Batran, Thomas Ettrich, Thorsten Götze, Barbara Grün, Georg Martin Haag, Vera Heuer, Ralf-Dieter Hofheinz, Nils Homann, Tobias Sebastian Bröring, Mariana Santos Cruz, Annika Kurreck, Sylvie Lorenzen, Nicolas Moosmann, Christian Müller, Markus Schuler, Gabriele Siegler, Mascha Binder, Eray Gökkurt
Publikováno v:
Frontiers in Oncology, Vol 13 (2023)
BackgroundEsophagogastric adenocarcinoma (EGA) presents a substantial global health challenge as the number of cases continues to rise. The current standard approach for treating localized EGA involves a combination of triplet chemotherapy, which con
Externí odkaz:
https://doaj.org/article/9aca2f640fe447fba35289be96b705be
Publikováno v:
JMIR Medical Education, Vol 9, p e43988 (2023)
BackgroundTeaching medicine is a complex task because medical teachers are also involved in clinical practice and research and the availability of cases with rare diseases is very restricted. Automatic creation of virtual patient cases would be a gre
Externí odkaz:
https://doaj.org/article/97f943aaf0aa421eb6a0f5ec43a8a41e
Autor:
Tim Frederik Weber, Manuela Spurny, Felix Christian Hasse, Oliver Sedlaczek, Georg Martin Haag, Christoph Springfeld, Theresa Mokry, Dirk Jäger, Hans-Ulrich Kauczor, Anne Katrin Berger
Publikováno v:
Insights into Imaging, Vol 11, Iss 1, Pp 1-11 (2020)
Abstract Objectives Our aim was to develop a structured reporting concept (structured oncology report, SOR) for general follow-up assessment of cancer patients in clinical routine. Furthermore, we analysed the report quality of SOR compared to conven
Externí odkaz:
https://doaj.org/article/3b71fe4857f6463c9e8f3a617e29744c
Autor:
Michael Schmucker, Martin Haag
Publikováno v:
JMIR Formative Research, Vol 5, Iss 9, p e28345 (2021)
BackgroundPediatric emergencies involving children are rare events, and the experience of emergency physicians and the results of such emergencies are accordingly poor. Anatomical peculiarities and individual adjustments make treatment during pediatr
Externí odkaz:
https://doaj.org/article/444b8acb66e544baa611da0455cc3c43
Autor:
Martin Haag, Susanne Knospe
Publikováno v:
Planung für Morgen ISBN: 9783868597929
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::86ce3eac840d58f4675082cad3b57a5e
https://doi.org/10.1515/9783868597929-020
https://doi.org/10.1515/9783868597929-020
Autor:
Hans-Christoph Friederich, Georg Martin Haag, Thomas Walle, Stefanie Zschäbitz, Imad Maatouk, Christina Sauer, Simeon Sauer, Senta Kiermeier
Publikováno v:
BMJ Open, Vol 11, Iss 7 (2021)
Introduction Immune checkpoint therapy (ICT) is associated with a distinct pattern of immune-related adverse events (irAEs) caused by inadvertently redirecting immune responses to healthy tissues. IrAEs can occur at any time; however, in most cases,
Externí odkaz:
https://doaj.org/article/980f2d699e7345a58ec6eee34d411baa
Autor:
Elena Busch, Aysel Ahadova, Kosima Kosmalla, Lena Bohaumilitzky, Pauline L. Pfuderer, Alexej Ballhausen, Johannes Witt, Jan-Niklas Wittemann, Hendrik Bläker, Elke Holinski-Feder, Dirk Jäger, Magnus von Knebel Doeberitz, Georg Martin Haag, Matthias Kloor
Publikováno v:
Frontiers in Oncology, Vol 11 (2021)
Immune checkpoint blockade (ICB) shows remarkable clinical effects in patients with metastatic microsatellite-unstable (MSI) cancer. However, markers identifying potential non-responders are missing. We examined the prevalence of Beta-2-microglobulin
Externí odkaz:
https://doaj.org/article/af5a317a8a3c4eed9d3bbbffc9e6c45c
Autor:
Ingmar F. Rompen, Henrik Nienhüser, Nerma Crnovrsanin, Julian Musa, Georg Martin Haag, Thomas Longerich, Timon Fiedler, Beat P. Müller-Stich, Leila Sisic, Adrian T. Billeter
Publikováno v:
Journal of Cancer. 14:1470-1478
Autor:
Anne Katrin Berger, Georg Martin Haag, Martin Ehmann, Anne Byl, Dirk Jäger, Christoph Springfeld
Publikováno v:
BMC Gastroenterology, Vol 17, Iss 1, Pp 1-7 (2017)
Abstract Background Pancreatic cancer occurs more frequently in older patients, but these are underrepresented in the phase III clinical studies that established the current treatment standards. This leads to uncertainty regarding the treatment of ol
Externí odkaz:
https://doaj.org/article/c1abf7c1aa43496bb4d4f3b9b4fa7ff2
Publikováno v:
BMC Cancer, Vol 17, Iss 1, Pp 1-8 (2017)
Abstract Background The optimal duration of firstline chemotherapy in metastatic esophagogastric cancer is unknown. In most clinical trials therapy was given until tumour progression or limiting toxicity. Maintenance concepts aiming to prolong the du
Externí odkaz:
https://doaj.org/article/393fbc2ef2e0465fa526d82d824630c7